UK Authorizes New Colorectal Cancer Screening Test
The DNA-based stool screening test is now authorized for marketing through the MHRA, expanding access to non-invasive CRC detection.
Read MorePosted by CLP Edit Staff | Sep 4, 2025 | Amplification Technologies |
The DNA-based stool screening test is now authorized for marketing through the MHRA, expanding access to non-invasive CRC detection.
Read MorePosted by CLP Edit Staff | Sep 2, 2025 | Molecular Diagnostic Analyzers |
Johns Hopkins-led study identifies protein signature with 98% accuracy in distinguishing ALS patients from healthy individuals and those with other neurological diseases.
Read MorePosted by CLP Edit Staff | Sep 2, 2025 | Analytical Software Systems |
Mount Sinai researchers develop machine learning approach that analyzes common clinical data to determine penetrance of rare genetic variants.
Read MorePosted by CLP Edit Staff | Aug 22, 2025 | Company News |
Cancer diagnostics company adds three clinical advisors and two board members to support commercial growth and platform expansion.
Read MorePosted by CLP Edit Staff | Aug 21, 2025 | Molecular Diagnostics |
The Salt Lake City-based company offers four targeted testing options that focus on how genetics influence responses to nutrition, fitness, sleep, and stress management.
Read More